drugset

drugset / Trial / NCT05195827

Effect of PRM-125 on Ambulatory Blood Pressure

NCT05195827 ↗

Phase 3 Withdrawn PRM Pharma, LLC

NaSingle-groupOpen-labelTreatment

Summary

Evaluation of Once-Daily PRM125 On Ambulatory Blood Pressure in Adults with Hypertension

Timeline

Start: 2021-12-20
Primary completion: 2022-09-30
Completion: 2022-11-30

Outcome

Outcome not reported

Stopped: “Sponsor”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	PRM-125	Unknown	—	—

Indications